Hutch News
Results per Page:
Antiviral immunity survives CD19-directed therapy
From the Hill and Turtle laboratories, Vaccine and Infections Disease Division and Clinical Research Division
Does CAR T-cell therapy leave patients vulnerable to infection?
$3.3M Cancer Moonshot grant to study how immunotherapy impacts patients’ ability to fight off bugs
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
Dr. Joshua Hill receives Amy Strelzer Manasevit grant award
Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections
First systematic study of infections after CAR T-cell therapy
“Benchmark” research could help reduce complications of emerging immunotherapy
Good News: iCMLf honors Dr. Jerald Radich, and more
Celebrating faculty and staff achievements
New project: CAR T cells for HIV cure?
Dr. Larry Corey wins $2.6M grant to investigate immunotherapy's potential to bring about long-term HIV remission
Fred Hutch staff, scientists participate in Life Sciences Research Weekend
Hutch scientists demo flu science, evolution at Pacific Science Center event